ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

8,646Medicare Part D Prescriptions Filled, Including Refills
$305K Total Retail Price of All Prescriptions
375 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
PRAVASTATIN SODIUM 323 238
METFORMIN HCL 300 189
OMEPRAZOLE 295 229
GABAPENTIN 242 147
HYDROCODONE-ACETAMINOPHEN 221 154 S3
LEVOTHYROXINE SODIUM 207 156
LISINOPRIL 202 155
GLIPIZIDE 187 133
FUROSEMIDE 175 150
AMLODIPINE BESYLATE 163 150
SIMVASTATIN 159 114
METOPROLOL TARTRATE 141 84
POTASSIUM CHLORIDE 132 119
TRIAMTERENE-HCTZ 129 110
AMOXICILLIN 128 91
SPIRONOLACTONE 122 100
ATENOLOL 122 66
NAPROXEN 118 60
WARFARIN SODIUM 115 86
CITALOPRAM HBR 115 90
RANITIDINE HCL 110 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 73
DOXAZOSIN MESYLATE 104 68
ENALAPRIL MALEATE 102 81
ISOSORBIDE MONONITRATE 92 79
PREDNISONE 90 80
BACLOFEN 89 68
LOVASTATIN 82 65
HYDROCHLOROTHIAZIDE 77 60
LOSARTAN POTASSIUM 77 49
GEMFIBROZIL 76 76
MELOXICAM 75 62
TRAMADOL HCL 73 40
CARVEDILOL 72 62
ACETAMINOPHEN-CODEINE 65 55 S3
ISOSORBIDE MONONITRATE ER 65 53
DOXYCYCLINE HYCLATE 64 48
CYCLOBENZAPRINE HCL 64 20 R
NEXIUM 62 49
DIGOXIN 62 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 40
METOPROLOL SUCCINATE 56 43
PROAIR HFA 55 36
DICLOFENAC SODIUM 54 38
PAROXETINE HCL 53 0
CIPROFLOXACIN HCL 52 46
SUCRALFATE 52 46
FLUOXETINE HCL 51 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.